Global Radiotherapy Market (2021-2026)

Dublin, July 01, 2021 (GLOBE NEWSWIRE) – The “Global Radiotherapy Market by Product (LINAC, CyberKnife, Gamma Knife, Tomotherapy, Particle Therapy, Cyclotron), Procedure (External (IMRT, IGRT, 3D-CRT) Internal (LDR, HDR)), Application (Prostate, Breast, Lung), End user (hospitals) – Forecast until 2026 “ the report was added to ResearchAndMarkets.com offer.

The global radiation therapy market is valued at USD 5.9 billion in 2021 and is expected to reach USD 7.3 billion by 2026, at a CAGR of 4.2% during the forecast period.

The growth of this market is mainly due to the increasing burden of target diseases and increasing investments, funds and grants for the development of new products.

In addition, the increasing adoption of radiation therapy procedures for the treatment of cancer, the increasing use of particle therapy for the treatment of cancer, and the growing number of conferences and symposia focusing on advances in radiation therapy are some- one of the other major factors in the growth of this market.

However, the underdeveloped public health infrastructure in emerging countries, the shortage of trained and qualified radiation oncologists, and the limited access and affordability of various radiation therapy treatment options are the main factors that are expected to hold back the development. growth of this market during the forecast period.

Prostate Cancer Segment, By Application, Accounted for the Largest Share of External and Internal Radiation Therapy Market in 2020

On the basis of application, the radiation therapy market is categorized into two main segments – external beam radiation therapy and internal beam radiation therapy / brachytherapy applications. Based on the indications, External Radiation Therapy Applications segment is divided into Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Head and Neck Cancer (Laryngeal Cancer, Hypopharyngeal Cancer, cancer of the oropharynx and cancer of the oral cavity) and other cancers (pancreatic cancer, brain cancer and gastrointestinal cancer, among others).

The prostate cancer segment accounted for a significant share of the EBRT and brachytherapy market due to the high and increasing prevalence of prostate cancer and the positive results of prostate cancer treatment with radiation therapy.

The particle therapy product segment, to record a significant growth rate among external beam radiation therapy products, due to new product launches and approvals

On the basis of the product, the radiation therapy market is segmented into external beam radiation therapy, internal radiation therapy / brachytherapy, and systemic radiation therapy products. The External Beam Radiation Therapy product segment is further divided into linear accelerators, particle therapy systems and conventional cobalt-60 teletherapy units.

Internal beam radiation therapy / brachytherapy product segment includes seeds, applicators, afterload devices and IORT systems, while systemic radiation therapy segment includes iobenguane (I-131), samarium- 153, rhenium-186 and other radioisotopes (yttrium-90, radium-223, phosphorus-32 and radiolabeled antibodies, among others).

Increased facilities and government initiatives to drive growth of hospital end user segment

Based on the end user, the radiotherapy market has been segmented into independent hospitals and radiotherapy centers. The hospital segment accounted for the largest share of the radiation therapy market due to the increasing global prevalence of cancer, the increase in facilities of advanced radiation therapy equipment in developed and developing regions, the increase in government initiatives to equip (or modernize) hospitals with newer and advanced equipment. radiation therapy systems and the increasing availability of funding for the adoption of advanced cancer treatment technologies.

In 2021, Shanghai Fudan University Children’s Hospital and Shanghai Fosun Healthcare (Group) Co., Ltd. (China) signed an agreement with Mevion Medical Systems to establish the first pediatric proton therapy center in China. Many other recent developments like this will drive the hospital end user segment market.

The US market, by region, held the largest market share in 2020

On the basis of region, the radiation therapy market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. North America held the bulk of the global radiation therapy market in 2020. The large share of the North American market can be attributed to such factors as ongoing technological advancements, increasing incidence of cancer, improvement. of the reimbursement scenario and the growing concentration of the main players on strengthening their presence in the region.

Main topics covered:

1. Introduction

2 Research methodology

3 Executive summary

4 premium information
4.1 Radiation Therapy Market Overview
4.2 Europe: External beam radiation therapy market, by product and by region
4.3 North America Internal Beam Radiation Therapy Market, by Application, 2021 vs. 2026 (million USD)
4.4 Geographic Overview of Radiation Therapy Market

5 Market overview
5.1 Presentation
5.2 Market dynamics
5.2.1 Drivers
5.2.1.1 Technological advances
5.2.1.2 Expansion of the target patient population
5.2.1.3 Increase in the number of conferences and seminars focused on raising awareness of the benefits of radiotherapy
5.2.1.4 Growing use of particle therapy for cancer treatment
5.2.2 Main market constraints
5.2.2.1 Lack of adequate health care infrastructure
5.2.2.2 Shortage of Qualified Oncologists / Radiologists
5.2.2.3 Affordability and accessibility of treatment
5.2.2.4 Complex nature of radiotherapy
5.2.3 Main Market Opportunities
5.2.3.1 Rise in health spending in developing countries
5.2.3.2 Increased public and private investments to meet the growing demand for cancer treatments
5.2.4 Challenges
5.2.4.1 Difficulty visualizing tumors during radiotherapy procedures
5.2.4.2 Risk of radiation exposure
5.3 Porter’s five forces analysis
5.4 Regulatory scenario
5.4.1 United States
5.4.2 Europe
5.4.3 Japan
5.4.4 Emerging countries
5.5 Repayment scenario
5.6 Ecosystem coverage
5.7 Value chain analysis
5.8 Impact of COVID-19 on the radiotherapy market
5.9 Price analysis
5.10 Patent analysis
5.10.1 Patent details

6 Radiotherapy Market, by Product

7 Radiotherapy Market, By Application

8 Radiotherapy market, by procedure

9 Radiotherapy Market, By End User

10 Radiotherapy Market, by Region

11 Competitive landscape

12 company profiles
12.1 Key players
12.1.1 Varian Medical Systems, Inc.
12.1.2 Elekta AB
12.1.3 Accuray Incorporated
12.1.4 Becton, Dickinson and company
12.1.5 IBA in the world
12.1.6 ViewRay, Inc.
12.1.7 IsoRay Medical
12.1.8 Hitachi Ltd.
12.1.9 Panacea Medical Technologies Pvt. Ltd.
12.1.10 Provision of health care
12.1.11 Mevion Medical Systems
12.1.12 Optivus Proton Therapy, Inc.
12.1.13 P-Cure
12.1.14 Sumitomo Heavy Industries Ltd.
12.1.15 Zeiss Group
12.2 Other players
12.2.1 IntraOp Medical, Inc.
12.2.2 iCAD, Inc.
12.2.3 Eckert and Ziegler
12.2.4 Sensus Health
12.2.5 SIT Sordina IORT Technologies SPA